Table 1.
Bone markers, BMD, 25(OH)D and TDF use
| a) All patients | b) 25(OH)D<50 nmol/L | |||||
|---|---|---|---|---|---|---|
| TDF cART (n = 293) | Non-TDF cART (n = 88) | P-value | TDF cART (n = 166) | Non-TDF cART (n = 49) | p Value | |
| PTH, ng/L, median (IQR) | 48 (36, 55) | 51 (39, 65) | 0.54 | 46 (36, 64) | 47 (38, 62) | 0.55 |
| Lumbar spine BMD, g/cm2, mean (SD) | 1.131 (0.146) | 1.149 (0.174) | 0.41 | 1.130 (0.153) | 1.156 (0.176) | 0.32 |
| Non-dominant total hip BMD, g/cm2, mean (SD) | 0.995 (0.133) | 0.986 (0.144) | 0.61 | 0.989 (0.140) | 0.997 (0.151) | 0.76 |
| Non-dominant femoral neck BMD, g/cm2, mean (SD) | 0.944 (0.124) | 0.945 (0.180) | 0.96 | 0.940 (0.129) | 0.935 (0.137) | 0.83 |
| P1NP, ng/mL, median (IQR) | 13.61 (5.55, 32.37) | 10.95 (5.52, 24.83) | 0.52 | 14.49 (5.83, 40.68) | 12.66 (6.48, 23.95) | 0.60 |
| CTX, ng/mL, median (IQR) | 1.94 (0.85, 4.84) | 2.39 (1.02, 5.33) | 0.29 | 2.02 (1.03, 4.84) | 2.48 (1.17, 5.65) | 0.32 |